Bavda Pharma Private Limited
About Bavda Pharma Private Limited
Data last updated:
Bavda Pharma Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U33110WB2021PTC242904.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Bal Krishan Agarwal and Neelu Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 620 New Alipur Block – O, Kolkata, West Bengal, India – 700053.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.94 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹5.18 Lakh (net margin 0.7%) and EBITDA of ₹14.26 Lakh (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 53% over three years.
As per MCA filings, the company has open charges of ₹71 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address620 New Alipur Block – O, Kolkata, West Bengal, India – 700053
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Bavda Pharma Private Limited
The main business activity of Bavda Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Bavda Pharma Private Limited FY 2025 filings available
Bavda Pharma Private Limited reported revenue of ₹6.94 Cr (up 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Bavda Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 53% over three years, including 12% growth in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Bavda Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹14.26 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.18 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Bavda Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bavda Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Bavda Pharma Private Limited
Bavda Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Other Hospital and Medical Care Activities). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cellbios Healthcare & Lifesciences Private Limited | ₹6.97 Cr (FY 2024) | •••• | •••• | -18.0% | •••• | Karapakkam, Tamil Nadu, India |
| Summit Physician Partners Private Limited | ₹6.96 Cr (FY 2025) | •••• | •••• | 84.0% | •••• | Hyderabad, Telangana, India |
| Action Foundation for Social Services | ₹6.96 Cr (FY 2025) | •••• | •••• | 97.0% | •••• | Bangalore, Karnataka, India |
| Dr. Punit's Esh Private Limited | ₹6.95 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Mumbai, Maharashtra, India |
| Aktivortho Private Limited | ₹6.95 Cr (FY 2025) | •••• | •••• | -23.0% | •••• | Vasant Vihar, Delhi, India |
| Bavda Pharma Private Limited this company | ₹6.94 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Kolkata, West Bengal, India |
| Pikag Business Datamatics Private Limited | ₹6.94 Cr (FY 2025) | •••• | •••• | 410.0% | •••• | Patan, Chhattisgarh, India |
| Sayesha Enterprises Private Limited | ₹6.94 Cr (FY 2024) | •••• | •••• | 73.0% | •••• | Kaithal, Haryana, India |
| Queens Healing Aesthetica Private Limited | ₹6.92 Cr (FY 2025) | •••• | •••• | 1128.0% | •••• | Mumbai, Maharashtra, India |
| Momentous Clinical Research Private Limited | ₹6.91 Cr (FY 2025) | •••• | •••• | -61.0% | •••• | Gandhinagar, Gujarat, India |
| Basal Healthcare India Private Limited | ₹6.91 Cr (FY 2025) | •••• | •••• | 94.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Bavda Pharma by revenue in the same principal business activity (Other Hospital and Medical Care Activities), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Bavda Pharma Private Limited
Bavda Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bal Krishan Agarwal Also directs: Bavda Pharmaceuticals Private Limited, Guru Sports LLP | Director | 02 Feb 2021 | 5 Years 8 Months | Current |
| Neelu Agarwal Also directs: Bavda Pharmaceuticals Private Limited | Director | 02 Feb 2021 | 5 Years 8 Months | Current |
| Rajat Agarwal Also directs: Bavda Pharmaceuticals Private Limited, Guru Sports LLP, Aan Infosol Private Limited and 1 more | Additional Director | 02 Feb 2026 | 0 Years 8 Months | Current |
Charges & Borrowings of Bavda Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Apr 2025 | Hdfc Bank Limited | ₹21 Lakh | Open |
| 03 Aug 2023 | Indian Overseas Bank | ₹50 Lakh | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Bavda Pharma Private Limited
Employment history and EPFO contributions of people linked to Bavda Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Bavda Pharma Private Limited
Bavda Pharma Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Rajat Agarwal was appointed as Additional Director on 02 Feb 2026.
Credit Ratings, Litigation & Regulatory Alerts for Bavda Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bavda Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bavda Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bavda Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bavda Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bavda Pharma Private Limited
Bavda Pharma is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 February 2021 (5+ years old) and is registered under CIN U33110WB2021PTC242904.
Bavda Pharma reported revenue of ₹6.94 Cr for FY 2025 (up 12% YoY).
Bavda Pharma has 3 current directors:
- Bal Krishan Agarwal - Director
- Neelu Agarwal - Director
- Rajat Agarwal - Additional Director
Bavda Pharma reported a net profit of ₹5.18 Lakh (net margin 0.7%) and EBITDA of ₹14.26 Lakh (EBITDA margin 2.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Bavda Pharma is 53% over three years. In the latest year (FY 2025) revenue rose 12%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Bavda Pharma is U33110WB2021PTC242904. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bavda Pharma was incorporated on 02 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Bavda Pharma by revenue are Cellbios Healthcare & Lifesciences Private Limited, Summit Physician Partners Private Limited, Action Foundation for Social Services, Dr. Punit's Esh Private Limited, Aktivortho Private Limited and 5 more, all in the same principal business activity (Other Hospital and Medical Care Activities).
Rajat Agarwal was appointed as Additional Director on 02 Feb 2026. Bal Krishan Agarwal was appointed as Director on 02 Feb 2021. Neelu Agarwal was appointed as Director on 02 Feb 2021.
The registered office of Bavda Pharma is at 620 New Alipur Block – O, Kolkata, West Bengal, India – 700053.
Bavda Pharma has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh.